{"id":"W2065796254","doi":"10.1016/j.jaac.2012.01.011","title":"Anhedonia Predicts Poorer Recovery Among Youth With Selective Serotonin Reuptake Inhibitor Treatment–Resistant Depression","year":2012,"lang":"en","type":"article","venue":"Journal of the American Academy of Child & Adolescent Psychiatry","topic":"Treatment of Major Depression","field":"Medicine","cited_by":461,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"University of California, Los Angeles; University of Pittsburgh; Valeant Pharmaceuticals International; National Institute of Mental Health; Pfizer; Rosalind Franklin University of Medicine and Science; Melissa Institute for Violence Prevention and Treatment; Kaiser Permanente; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; H. Lundbeck A/S; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Anhedonia; Serotonin reuptake inhibitor; Depression (economics); Psychology; Context (archaeology); Psychiatry; Randomized controlled trial; Clinical psychology; Internal medicine; Antidepressant; Medicine; Schizophrenia (object-oriented programming)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01077848638004594,"score_gpt":0.2587964946050663,"score_spread":0.2480180082250204,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}